Clinical trial
A Study in Participants With Diabetic Kidney Disease
NCT01113801
Study timeline
Study start (unknown)2010-07-01Date precision: month
Registry last updated2019-09-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetic Kidney Diseaseunresolved
Diabetic Nephropathyunresolved
Diabetic Glomerulosclerosisunresolved
Interventions
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
Los AngelesCalifornia, United States1DallasTexas, United States1AtlantaGeorgia, United States1TampaFlorida, United States1DurhamNorth Carolina, United States1PhoenixArizona, United States1DenverColorado, United States1OmahaNebraska, United States1CharlotteNorth Carolina, United States1Chapel HillNorth Carolina, United States1Winston-SalemNorth Carolina, United States1BudapestHungary1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01113801 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.